DrugPatentWatch Database Preview
Profile for Israel Patent: 189677
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Israel Patent: 189677
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Oct 19, 2021 | Eisai Inc | LENVIMA | lenvatinib mesylate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |